Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 16 de 16
Filtrar
1.
Cardiovasc J Afr ; 33(3): 138-144, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-34851354

RESUMEN

BACKGROUND: Little is known about the clinical profile and management of patients with acute coronary syndromes (ACS) in the South African public sector. METHODS: We conducted a retrospective study of patients presenting with ACS to a secondary-level healthcare facility in Cape Town during a one-year period to study the clinical profile and management of these patients. RESULTS: Among the 214 patients in this cohort, 48 (27.5%) had ST-segment elevation myocardial infarction (STEMI), 43 (24.7%) had non-ST-segment elevation myocardial infarction and 83 (47.7%) unstable angina pectoris. We identified high rates of >12-hour delays in first medical contact after symptom onset (46%) and inaccurate ECG diagnosis of STEMI (29.2%), which were associated with low rates of thrombolysis (39.6%). High rates of non-adherence and ACS recurrence were also observed. CONCLUSION: To address the local challenges in ACS management highlighted in this study, we propose the development of a regional referral network prioritising access to expedited care and primary reperfusion interventions in ACS.


Asunto(s)
Síndrome Coronario Agudo , Infarto del Miocardio , Infarto del Miocardio sin Elevación del ST , Infarto del Miocardio con Elevación del ST , Síndrome Coronario Agudo/diagnóstico , Síndrome Coronario Agudo/epidemiología , Síndrome Coronario Agudo/terapia , Atención a la Salud , Humanos , Infarto del Miocardio/diagnóstico , Estudios Retrospectivos , Infarto del Miocardio con Elevación del ST/diagnóstico , Infarto del Miocardio con Elevación del ST/epidemiología , Infarto del Miocardio con Elevación del ST/terapia , Sudáfrica/epidemiología
2.
Aesthetic Plast Surg ; 45(1): 332-339, 2021 02.
Artículo en Inglés | MEDLINE | ID: mdl-33051719

RESUMEN

BACKGROUND: Surgical bleeding may lead to the need for blood transfusion and minimizing blood loss has been a basic principle followed by surgeons for generations. Antifibrinolytic agents are widely used to reduce perioperative haemorrhage. The present study sought to assess the efficacy of directly infiltrated tranexamic acid in ameliorating bruising in participants undergoing cosmetic plastic surgery (liposuction). MATERIALS AND METHODS: The study employed a blinded, prospective, randomized, case control design. Thirty-three patients were studied. Tranexamic acid free infiltration tumescent solution (saline, bupivacaine lignocaine and adrenalin) was infiltrated to one flank of patients undergoing liposuction of flanks. The other flank was infiltrated with the same tumescent solution (saline, bupivacaine lignocaine and adrenalin) mixed with tranexamic acid (0.1%). Bruises were photographed one and seven days after surgery and measured for size. The surface area of the bruises was calculated using ImageJ software. We compared the bruised surface are between the tranexamic acid infiltrated flank and non-tranexamic acid infiltrated flank in the same patient. The model employed involved measuring the bruises on each flank of the same patient, with surgery by a single surgeon using the same infiltration and surgical techniques for both sides. The only variable was the difference in tranexamic acid concentration between study and control flanks. RESULTS: We found that use of tranexamic acid consistently resulted in a smaller bruise area on days one and seven after liposuction of flanks. Results were statistically significant. CONCLUSIONS: This is the first study examining addition of tranexamic acid to a tumescent infiltration solution-to produce a predictable local concentration of tranexamic acid-in order to maximize surgical site effect and minimize systemic effect. The authors recommend incorporation of tranexamic acid as a routine component along with adrenaline and local anaesthetics in tumescent field infiltration solution 10-15 min before commencement of the cosmetic surgery. LEVEL OF EVIDENCE II: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .


Asunto(s)
Antifibrinolíticos , Cirugía Plástica , Ácido Tranexámico , Anestésicos Locales , Humanos , Estudios Prospectivos , Resultado del Tratamiento
3.
S Afr J Surg ; 57(3): 11-16, 2019 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-31392859

RESUMEN

BACKGROUND: Living donor liver transplantation (LDLT) plays a crucial role in liver transplant programmes, particularly in regions with a scarcity of deceased donor organs and especially for paediatric recipients. LDLT is a complex and demanding procedure which places a healthy living donor in harm's way. Donor safety is therefore the overriding concern. This study aimed to report our standardised approach to the evaluation, technical aspects and outcomes of LDLT donor hepatectomy at Wits Donald Gordon Medical Centre. METHOD: The study population consisted of all patients undergoing LDLT donor hepatectomy since the inception of the programme in March 2013 until 2018. Sixty five living donor hepatectomies were performed. Primary outcome measures included donor demographics, operative time, peak bilirubin, aspartate and alanine transaminase levels postoperatively, length of hospital stay and postoperative complications using the Clavien-Dindo classification. RESULTS: The majority of the donors were female, most were parents with mothers being the donor almost 85% of the time. The median operative time was 374 minutes with a downward trend over time as experience was gained. The median length of hospital stay was 7 days. There was no mortality and the complication rate was 30% with the majority being minor (Grade 1). CONCLUSION: Living donor liver transplant from adult-to-child has been successfully initiated in South Africa. Living donor hepatectomy can be safely performed with acceptable outcomes for the donor. Wait-list mortality however remains unacceptably high. Expansion of LDLT as well as real change in deceased donor policy is required to address this issue.


Asunto(s)
Hepatectomía/efectos adversos , Donadores Vivos , Femenino , Hepatectomía/métodos , Humanos , Tiempo de Internación , Trasplante de Hígado , Masculino , Tempo Operativo , Sudáfrica
4.
S Afr Med J ; 109(7): 471-476, 2019 Jun 28.
Artículo en Inglés | MEDLINE | ID: mdl-31266571

RESUMEN

For more than 70 years the default therapy for anaemia and blood loss was mostly transfusion. Accumulating evidence demonstrates a significant dose-dependent relationship between transfusion and adverse outcomes. This and other transfusion-related challenges led the way to a new paradigm. Patient blood management (PBM) is the application of evidence-based practices to optimise patient outcomes by managing and preserving the patient's own blood. 'Real-world' studies have shown that PBM improves patient outcomes and saves money. The prevalence of anaemia in adult South Africans is 31% in females and 17% in males. Improving the management of anaemia will firstly improve public health, secondly relieve the pressure on the blood supply, and thirdly improve the productivity of the nation's workforce. While high-income countries are increasingly implementing PBM, many middle- and low-income countries are still trying to upscale their transfusion services. The implementation of PBM will improve South Africa's health status while saving costs.


Asunto(s)
Transfusión de Sangre Autóloga/normas , Nivel de Atención , Anemia/terapia , Pérdida de Sangre Quirúrgica , Países Desarrollados , Países en Desarrollo , Medicina Basada en la Evidencia , Humanos , Seguridad del Paciente , Desarrollo de Programa , Sudáfrica
5.
Br J Anaesth ; 118(1): 90-99, 2017 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-28039246

RESUMEN

BACKGROUND: Service models for gastrointestinal endoscopy sedation must be safe, as endoscopy is the most common procedure performed under sedation in many countries. The aim of this prospective cohort study was to determine the patient risk profile, and incidence of and risk factors for significant unplanned events, in adult patients presenting for gastrointestinal endoscopy in a group of university-affiliated hospitals where most sedation is managed by anaesthetists. METHODS: Patients aged ≥18 yr presenting for elective and emergency gastrointestinal endoscopy under anaesthetist-managed sedation at nine hospitals affiliated with the University of Melbourne, Australia, were included. Outcomes included significant airway obstruction, hypoxia, hypotension and bradycardia; unplanned tracheal intubation; abandoned procedure; advanced life support; prolonged post-procedure stay; unplanned over-night admission and 30-day mortality. RESULTS: 2,132 patients were included. Fifty percent of patients were aged >60 yr, 50% had a BMI >27 kg m -2, 42% were ASA physical status III-V and 17% were emergency patients. The incidence of significant unplanned events was 23.0% (including significant hypotension 11.8%). Significant unplanned intraoperative events were associated with increasing age, BMI <18.5 kg m -2, ASA physical status III-V, colonoscopy and planned tracheal intubation. Thirty-day mortality was 1.2% (0.2% in electives and 6.0% in emergencies) and was associated with ASA physical status IV-V and emergency status. CONCLUSIONS: Patients presenting for gastrointestinal endoscopy at a group of public university-affiliated hospitals where most sedation is managed by anaesthetists, had a high risk profile and a substantial incidence of significant unplanned intraoperative events and 30-day mortality.


Asunto(s)
Sedación Consciente/efectos adversos , Endoscopía Gastrointestinal/efectos adversos , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Índice de Masa Corporal , Endoscopía Gastrointestinal/mortalidad , Femenino , Hospitales Universitarios , Humanos , Masculino , Persona de Mediana Edad , Seguridad del Paciente , Estudios Prospectivos , Adulto Joven
6.
S Afr Med J ; 103(4 Pt 2): 261-7, 2013 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-23547704

RESUMEN

BACKGROUND: Pharmacological prophylactic anticoagulation in many countries, including South Africa, is under-prescribed. This has resulted in unacceptable rates of morbidity and mortality. METHOD: The Southern African Society of Thrombosis and Haemostasis held a meeting to update the previous guideline and review new literature including guidelines from other societies. The following specialties were represented on the committees: anaesthetics, cardiology, clinical haematology, critical care, obstetrics and gynaecology, haematopathology, internal medicine, neurology, orthopaedic surgery and pulmonology. A draft document was presented at the meeting, which was then revised by consensus agreement. To avoid local bias, the guideline was adjudicated by recognised international external experts. RESULTS AND CONCLUSION: A concise, practical updated guideline for thromboprophylaxis and treatment in medical and surgical patients has been produced for South African conditions. It is hoped that this guideline will continue to improve anticoagulation practice in this country, which we believe will directly benefit patient outcomes.


Asunto(s)
Anticoagulantes , Hemorragia , Cuidados Preoperatorios/métodos , Prevención Secundaria/métodos , Filtros de Vena Cava , Tromboembolia Venosa , Anticoagulantes/administración & dosificación , Anticoagulantes/efectos adversos , Bencimidazoles/administración & dosificación , Bencimidazoles/efectos adversos , Quimioprevención/métodos , Dabigatrán , Manejo de la Enfermedad , Relación Dosis-Respuesta a Droga , Sistemas de Liberación de Medicamentos/métodos , Monitoreo de Drogas/métodos , Sustitución de Medicamentos/métodos , Hemorragia/inducido químicamente , Hemorragia/prevención & control , Hemorragia/terapia , Heparina de Bajo-Peso-Molecular/administración & dosificación , Heparina de Bajo-Peso-Molecular/efectos adversos , Humanos , Relación Normalizada Internacional , Morfolinas/administración & dosificación , Morfolinas/efectos adversos , Medición de Riesgo , Factores de Riesgo , Rivaroxabán , Tiofenos/administración & dosificación , Tiofenos/efectos adversos , Factores de Tiempo , Tromboembolia Venosa/clasificación , Tromboembolia Venosa/diagnóstico , Tromboembolia Venosa/prevención & control , Tromboembolia Venosa/terapia , beta-Alanina/administración & dosificación , beta-Alanina/efectos adversos , beta-Alanina/análogos & derivados
7.
J Clin Pharm Ther ; 31(2): 167-72, 2006 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-16635051

RESUMEN

OBJECTIVE: An extemporaneous suspension of tacrolimus for paediatric use has recently been developed but poor bioavailability and erratic plasma concentrations were observed during clinical use. It was not clear whether this was due to changes in the physical properties of the suspension during storage. The aim of this work was to investigate the physical and microbiological stability over the recommended 8-week shelf-life of this extemporaneous tacrolimus suspension. METHODS: Suspensions (0.5 mg/mL) were custom made by a special manufacturer under Good Manufacturing Practice conditions. The procedure involved mixing tacrolimus capsule contents into Ora Plus and Simple Syrup (1 : 1) using a mortar and pestle followed by an homogenization step. The particle sizes of the suspensions were measured using a MasterSizer. A light microscope equipped with polarizers was used to visualize any particle size changes or crystal growth. Viable bacterial and fungal contamination was assessed using standard colony count techniques on solid media. The suspensions were kept at 22-26 degrees C and evaluated weekly. RESULTS: The volume mean diameter d((4,3)) from laser diffraction did not change significantly. Light microscopy did not reveal any significant change in particle size or crystal growth. Contamination by viable and culturable micro-organisms could not be detected. CONCLUSION: The suspension was physically (particle size) and microbiologically stable during the 8-week study period suggesting other factors including poor dosing could be responsible for the pharmacokinetic variation observed during clinical use which warrants further investigation.


Asunto(s)
Química Farmacéutica/métodos , Inmunosupresores/farmacocinética , Tacrolimus/farmacocinética , Disponibilidad Biológica , Contaminación de Medicamentos , Estabilidad de Medicamentos , Tamaño de la Partícula , Pediatría , Suspensiones
9.
Appl Microbiol Biotechnol ; 64(1): 76-85, 2004 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-14666389

RESUMEN

Biocatalytic transformations converting aromatic and arylaliphatic nitriles into the analogous related amide or acid were investigated. These studies included synthesis of the beta-substituted nitrile 3-hydroxy-3-phenylpropionitrile, subsequent enrichment and isolation on this substrate of nitrile-degrading microorganisms from the environment, and a comparative study of enzymatic reactions of nitriles by resting cell cultures and enzymes. Each biocatalyst exhibited a distinctive substrate selectivity profile, generally related to the length of the aliphatic chain of the arylaliphatic nitrile and the position of substituents on the aromatic ring or aliphatic chain. Cell-free nitrilases generally exhibited a narrower substrate range than resting whole cells of Rhodococcus strains. The Rhodococcus strains all exhibited nitrile hydratase activity and converted beta-hydroxy nitriles (but did not demonstrate enantioselectivity on this substrate). The biocatalysts also mediated the synthesis of a range of alpha-hydroxy carboxylic acids or amides from aldehydes in the presence of cyanide. The use of an amidase inhibitor permits halting the nitrile hydratase/amidase reaction at the amide intermediate.


Asunto(s)
Acetaldehído/análogos & derivados , Aminohidrolasas/metabolismo , Bacterias/enzimología , Bacterias/aislamiento & purificación , Hidroliasas/metabolismo , Nitrilos/metabolismo , Acetaldehído/metabolismo , Amidohidrolasas/metabolismo , Aminohidrolasas/aislamiento & purificación , Bacillus/enzimología , Bacillus/crecimiento & desarrollo , Bacillus/aislamiento & purificación , Bacillus/metabolismo , Bacterias/crecimiento & desarrollo , Bacterias/metabolismo , Biotransformación , Ácidos Carboxílicos/metabolismo , Catálisis , Sistema Libre de Células/metabolismo , Hidroliasas/aislamiento & purificación , Hidrólisis , Cinética , Estructura Molecular , Nitrilos/química , Pseudomonas/enzimología , Pseudomonas/crecimiento & desarrollo , Pseudomonas/aislamiento & purificación , Pseudomonas/metabolismo , Rhodococcus/enzimología , Rhodococcus/crecimiento & desarrollo , Rhodococcus/aislamiento & purificación , Rhodococcus/metabolismo , Microbiología del Suelo , Estereoisomerismo , Especificidad por Sustrato
10.
S Afr Med J ; 83(7): 501-5, 1993 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-8211490

RESUMEN

The 10 months after the introduction of the first acute pain relief service (APRS) in southern Africa is described. Seven hundred patients were treated with morphine by means of patient-controlled analgesia (PCA), administered to patients after major surgery or extensive burns via the intravenous (IV) or subcutaneous (SC) route. The efficacy, safety and resource implications were assessed. The results showed that pain control was good, with the majority of patients (66%) experiencing mild pain during the first 24 hours. The pump was used by each patient for an average of 4.32 days. The mean total dose of morphine used was 105.2 mg via the IV route and 114.6 mg via the SC route. Over the 10 months, the 25 PCA pumps worked 80,000 pump-hours; only 3 pumps malfunctioned. A total of 86,861 mg morphine was used during this period with rare morbidity and no mortality. Only 1 patient experienced sedation and respiratory depression. The benefits of an APRS with PCA to patients and medical staff alike are discussed.


Asunto(s)
Analgesia Controlada por el Paciente/métodos , Morfina/administración & dosificación , Dolor Postoperatorio/tratamiento farmacológico , Dolor/tratamiento farmacológico , Adolescente , Adulto , Anciano , Analgesia Controlada por el Paciente/efectos adversos , Analgesia Controlada por el Paciente/instrumentación , Estudios de Evaluación como Asunto , Femenino , Humanos , Masculino , Cuerpo Médico de Hospitales , Persona de Mediana Edad , Sudáfrica
11.
S Afr J Surg ; 30(4): 165-7, 1992 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-1363492

RESUMEN

An unexplained hypertensive response during the induction of anaesthesia for phaeochromocytoma resection is described. This response was not accompanied by elevations in plasma catecholamine levels. It occurred despite heavy premedication and followed induction with etomidate, alfentanil, lignocaine, vecuronium and magnesium sulphate (MgSO4). A bolus of esmolol (0.5 mg/kg) lowered the blood pressure rapidly. Subsequent haemodynamic manipulations were carried out by varying the rate of an esmolol infusion. A constant background infusion of MgSO4 was maintained throughout the procedure. These produced satisfactory haemodynamic control despite marked rises in plasma catecholamine levels.


Asunto(s)
Anestesia General/efectos adversos , Hipertensión/inducido químicamente , Neoplasias de las Glándulas Suprarrenales/cirugía , Adulto , Alfentanilo/efectos adversos , Etomidato/efectos adversos , Femenino , Humanos , Hipertensión/terapia , Laringoscopía , Lidocaína/efectos adversos , Feocromocitoma/cirugía , Bromuro de Vecuronio/efectos adversos
12.
S Afr J Surg ; 30(1): 5-6, 1992 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-1566203

RESUMEN

Postoperative morphine requirements were assessed for the first 48 hours after surgery in 93 consecutive patients undergoing elective or emergency laparotomies. Analgesia was provided by patient-controlled analgesic (PCA) pumps. Daily morphine utilisation was recorded. At the conclusion of PCA therapy, patients were asked to assess their quality of analgesia. Eighty-one patients, who reported good or excellent pain relief, were included in the study. Data are presented demonstrating the wide variation in morphine requirements necessary to produce this level of analgesia.


Asunto(s)
Analgesia Controlada por el Paciente , Morfina/administración & dosificación , Dolor Postoperatorio/tratamiento farmacológico , Adulto , Humanos , Individualidad
14.
S Afr Med J ; 81(2): 74-6, 1992 Jan 18.
Artículo en Inglés | MEDLINE | ID: mdl-1733027

RESUMEN

Patient-controlled analgesia (PCA) is a well-established technique for the relief of acute and chronic pain. It is widely used in Western hospitals. Patient and staff education is required to provide successful analgesia. This paper reports the successful introduction of PCA on a large scale in a provincial hospital. The considerable potential difficulties in communication and education appear to have been overcome. The widespread introduction of PCA in all our hospitals would appear to be feasible.


Asunto(s)
Analgesia Controlada por el Paciente , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Analgesia Controlada por el Paciente/métodos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Morfina/administración & dosificación , Dolor Postoperatorio/prevención & control , Sudáfrica
15.
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...